GLP-1 FOR PCOS WEIGHT LOSS

Why weight is harder to lose with PCOS

Polycystic ovary syndrome is commonly associated with insulin resistance, where the body produces more insulin to achieve the same effect. Raised insulin promotes fat storage and makes weight loss through calorie restriction alone considerably harder.

That creates a loop: insulin resistance drives weight gain, and additional weight worsens insulin resistance. Many women with PCOS describe doing everything correctly with disproportionately little result, and the physiology supports that experience.

This is a metabolic problem, not a discipline problem, and framing it correctly matters for choosing treatment.

How GLP-1 medicines address it

GLP-1 receptor agonists reduce appetite and slow gastric emptying, making a calorie deficit achievable. They also improve glucose handling and insulin sensitivity, which addresses the underlying driver rather than only the symptom.

Tirzepatide acts on both GIP and GLP-1 pathways, and its effect on glucose control is well established, which is why it was approved for type 2 diabetes first.

For women whose PCOS is accompanied by prediabetes or type 2 diabetes, that dual benefit is particularly relevant.

Patient outcomes from supervised programmes at our clinic, published with consent and with faces obscured for privacy. Individual results vary.

What improvement is realistic

Published research shows that a weight reduction of around five to ten percent can meaningfully improve menstrual regularity, androgen levels and insulin sensitivity in PCOS.

That is a considerably lower threshold than many patients expect, and it means benefit often appears well before a target weight is reached.

Individual response varies. Some women see cycles regularise within months; others see metabolic markers improve while cycles take longer.

Fertility: an important consideration

Weight loss can restore ovulation in women with PCOS who were not ovulating. That is frequently the goal, but it also means fertility may return unexpectedly.

GLP-1 medicines are not used in pregnancy and are typically stopped a defined period before planned conception. Your doctor will advise on timing.

Contraception should be discussed before starting treatment, not after. This is a conversation we have with every PCOS patient at assessment.

Where metformin fits

Metformin has long been used in PCOS for insulin resistance and remains appropriate for many women. It is considerably cheaper and has a very long safety record.

GLP-1 medicines produce substantially greater weight reduction, but cost more and are newer. The two are sometimes used together, which is a clinical decision for your doctor.

Which is right for you depends on your BMI, your metabolic markers, whether fertility is a near-term goal, and what you have already tried.

Nutrition that suits PCOS

Protein at every meal, adequate fibre, and attention to how carbohydrates are distributed through the day all help with insulin response. Our dietitians build this around Indian meals rather than an imported template.

Resistance training is particularly valuable in PCOS, because muscle improves glucose disposal independently of weight change.

Sleep and stress management matter more here than in general weight management, since both affect insulin sensitivity directly.

How treatment is supervised

Assessment covers your cycle history, any fertility plans, current medications including hormonal contraception, and blood work including glucose, insulin, thyroid and androgen markers where relevant.

Reviews track weight, waist measurement, cycle changes and metabolic markers, not weight alone. Improvement in PCOS is measured on more than one axis.

If a gynaecologist or endocrinologist is already involved in your care, treatment is coordinated with them rather than run in parallel.

What to expect month by month with PCOS

The first month is dose titration, and appetite change is the main thing you will notice. Metabolic markers rarely shift meaningfully this early.

Months two and three typically show a clearer weight trend as doses escalate. Some women notice cycle changes in this window, though many do not yet.

Months four to six are where insulin sensitivity improvements tend to become measurable and where menstrual regularity most commonly improves. This is also when androgen-related symptoms such as skin changes may begin to respond.

Improvement in PCOS is measured on several axes, so reviews should track cycle history and metabolic markers alongside weight rather than weight alone.

Managing PCOS-specific side effects

Women with PCOS frequently already experience bloating and digestive irregularity, and the medicine can compound this initially. Slow titration matters even more in this group.

Where hormonal contraception is in use, absorption may be affected by slowed gastric emptying. This should be reviewed at prescribing rather than assumed to be unchanged.

Fatigue is common in PCOS independently, and reduced intake can worsen it. Iron, vitamin D and B12 should be checked at baseline and during treatment, since deficiency is more prevalent in this group.

Hair thinning during rapid weight loss can be particularly distressing where androgenic hair changes already exist. Adequate protein and monitored nutrition reduce this risk.

Coordinating with your gynaecologist

Many women with PCOS are already under a gynaecologist or endocrinologist. Weight management should be coordinated with that care rather than run separately, particularly where fertility treatment is planned or ongoing.

Bring recent hormone panels, ultrasound reports and any current prescriptions to your assessment. This avoids duplicate testing and prevents medication conflicts.

If ovulation induction or IVF is planned, the timing of stopping weight loss medication becomes a shared decision between your treating doctors.

We are happy to communicate directly with your existing specialist.

Frequently asked questions